Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
OneMedNet Corp. (ONMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: ONMD (3-star) is a REGULAR-BUY. BUY since 16 days. Profits (77.78%). Updated daily EoD!
Upturn Star Rating
Moderate Performance
These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit 85.03% | Avg. Invested days 53 | Today’s Advisory Regular Buy |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  4.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 15.74M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.76 | 52 Weeks Range 0.30 - 1.60 | Updated Date 06/29/2025 |
52 Weeks Range 0.30 - 1.60 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.34 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) -1623.36% |
Management Effectiveness
Return on Assets (TTM) -489.93% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 22828402 | Price to Sales(TTM) 29.6 |
Enterprise Value 22828402 | Price to Sales(TTM) 29.6 | ||
Enterprise Value to Revenue 42.91 | Enterprise Value to EBITDA 16.73 | Shares Outstanding 30572800 | Shares Floating 15312402 |
Shares Outstanding 30572800 | Shares Floating 15312402 | ||
Percent Insiders 59.62 | Percent Institutions 13.71 |
Upturn AI SWOT
OneMedNet Corp.
Company Overview
History and Background
OneMedNet Corporation provides secure, cloud-based solutions that aggregate imaging data to advance research and improve patient outcomes. Founded to address the challenges of siloed medical imaging data, OneMedNet has evolved into a leading provider of clinical image exchange and research solutions.
Core Business Areas
- Clinical Image Exchange: Facilitates the secure sharing of medical images between healthcare providers and patients.
- Research Data Solutions: Provides access to de-identified medical imaging data for research purposes, enabling pharmaceutical companies and research institutions to accelerate drug discovery and improve patient care.
- Image Aggregation and Management: Offers services to aggregate and manage medical images from various sources, ensuring data quality and standardization.
Leadership and Structure
The leadership team consists of experienced executives in healthcare, technology, and finance. The company structure is hierarchical, with departments focused on sales, marketing, technology, and operations.
Top Products and Market Share
Key Offerings
- OneMedNet iRWD: A cloud-based platform that enables researchers to access and analyze de-identified medical imaging data from multiple sources. Market share data unavailable. Competitors include Flywheel.io, VIDA Diagnostics, and Arterys.
- OneMedNet Ascend: A clinical image exchange platform that allows healthcare providers to securely share medical images with each other. Market share data unavailable. Competitors include Life Image, Ambra Health, and Nuance PowerShare.
Market Dynamics
Industry Overview
The medical imaging market is experiencing significant growth due to technological advancements, increasing demand for diagnostic imaging, and the rising prevalence of chronic diseases. The industry is competitive, with numerous companies offering imaging solutions.
Positioning
OneMedNet positions itself as a leading provider of secure, cloud-based solutions for clinical image exchange and research data. Its competitive advantages include its focus on data privacy and security, its ability to aggregate data from multiple sources, and its expertise in medical imaging.
Total Addressable Market (TAM)
The global medical imaging market is projected to reach hundreds of billions of dollars. OneMedNet is positioned to capture a portion of this market by providing innovative solutions for clinical image exchange and research data access. Exact figures can fluctuate.
Upturn SWOT Analysis
Strengths
- Secure cloud-based platform
- Expertise in medical imaging data
- Strong focus on data privacy and security
- Ability to aggregate data from multiple sources
Weaknesses
- Limited brand recognition
- Smaller market share compared to larger competitors
- Dependence on regulatory compliance
Opportunities
- Expanding into new geographic markets
- Developing new imaging solutions
- Forming partnerships with healthcare providers and research institutions
- Increased adoption of cloud-based solutions
Threats
- Increasing competition
- Rapid technological advancements
- Changes in regulatory requirements
- Economic downturns
Competitors and Market Share
Key Competitors
- LIFE (Life Image)
- DCTH (Delcath Systems, Inc.)
- IMGN (ImmunoGen, Inc.)
Competitive Landscape
OneMedNet faces competition from larger, more established companies in the medical imaging market. Its ability to differentiate itself through innovation, data privacy, and customer service will be crucial for its success.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data unavailable. Historical financials needed to ascertain the trajectory.
Future Projections: Future projections depend on market conditions, competition, and the company's ability to execute its strategic initiatives. Analyst estimates are required to complete this section.
Recent Initiatives: Recent initiatives are not readily available without specific announcements or press releases from the company.
Summary
OneMedNet Corp. is a company in the medical imaging market that offers secure, cloud-based solutions for clinical image exchange and research data. It has strengths in data privacy and security but faces challenges from larger competitors and market dynamics. Its growth potential hinges on its ability to innovate, expand its market presence, and adapt to changing regulatory requirements. More financial and operational information are needed to assess the company effectively.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website (Limited)
- Industry Reports (General)
- News Articles (Limited)
Disclaimers:
The information provided is for informational purposes only and should not be considered as financial advice. The analysis is based on limited publicly available data and may not be complete or accurate. Consult a financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OneMedNet Corp.
Exchange NASDAQ | Headquaters Eden Prairie, MN, United States | ||
IPO Launch date 2023-11-08 | CEO, President & Director Mr. Aaron Green | ||
Sector Healthcare | Industry Health Information Services | Full time employees 22 | Website https://www.onemednet.com |
Full time employees 22 | Website https://www.onemednet.com | ||
OneMedNet Corporation, a healthcare software company, provides digital medical image management, exchange, and sharing solutions in the Americas, Europe, and the Middle East. The company offers iRWD, which provides regulatory grade imaging and clinical data in the pharmaceutical, device manufacturing, contract research organizations, and artificial intelligence markets markets; and BEAM, a medical imaging exchange platform between hospital/healthcare systems, imaging centers, physicians, and patients. OneMedNet Corporation is headquartered in Eden Prairie, Minnesota.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.